What You Should Know:
– Precision for Medicine, a provider of next-generation drug development research and services, and PathAI, a global leader in digital pathology, announced a strategic collaboration today.
– The partnership aims to jointly…
Continue Reading
With an initial investment of $10 million, Leidos, a technology services vendor in the healthcare, national security, energy and other sectors, said it hopes to accelerate the use of artificial intelligence for detecting and…
Continue Reading
Technology company Leidos is pouring $10 million into a plan to use AI to detect and manage diseases.The company is working with the University of Pittsburgh’s Computational Pathology and AI Center of Excellence (CPACE)…
Continue Reading
What You Should Know:
– Endeavor Health, a Chicagoland-based integrated health system announced the development of a groundbreaking, fully cloud-based digital pathology platform in collaboration with Google Cloud, establishing a novel model poised to reshape…
Continue Reading
Peninsula Pathology Network has partnered with UK cloud, connectivity, communications and cyber security provider, Exponential-e to implement a secure private cloud environment.
The network, which brings together pathology services at five sites in Devon, Cornwall…
Health technology company Royal Philips has expanded its partnership with Ibex Medical Analytics that includes a new release of Philips IntelliSite Pathology Solution (PIPS) to speed up adoption of AI-enabled digital pathology tools. In 2021,…
Continue Reading
What You Should Know:
– Proscia, a software company focused on digitizing and applying AI to pathology, has announced a $50M funding round, bringing its total capital raised to $130M.
– The funding, led by Insight…
Continue Reading
What You Should Know:
– elea, an innovative AI platform designed to supercharge healthcare professionals’ ability to deliver life-saving diagnoses and care, has announced a $4.3M (€4M)funding round led by Fly Ventures and Giant Ventures.
–…
Continue Reading
Digital pathology and artificial intelligence (AI) hold immense transformative potential to revolutionize cancer diagnostics, treatment outcomes, and biomarker discovery. Gaining a deeper understanding of deep learning algorithm methods applied to histopathological data and evaluating…
Continue Reading
What You Should Know:
– Tempus, a provider of AI-driven precision medicine, and Stemline Therapeutics, Inc. (“Stemline”), a wholly-owned subsidiary of the Menarini Group announced a new collaboration to improve the use of ESR1 testing…
Continue Reading
